Entry
Name
JAK-STAT signaling pathway
Description
The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals, from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. Following the binding of cytokines to their cognate receptor, STATs are activated by members of the JAK family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. In addition to the activation of STATs, JAKs mediate the recruitment of other molecules such as the MAP kinases, PI3 kinase etc. These molecules process downstream signals via the Ras-Raf-MAP kinase and PI3 kinase pathways which results in the activation of additional transcription factors.
Class
Environmental Information Processing; Signal transduction
BRITE hierarchy
Pathway map
Other DBs
Orthology
K00922 PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153 ]
K02161 BCL2; apoptosis regulator Bcl-2
K02539 MCL1; myeloid leukemia cell differntiation protein MCL-1
K02649 PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K04357 EGF; epidermal growth factor
K04359 PDGFA; platelet-derived growth factor subunit A
K04363 PDGFRA, CD140A; platelet-derived growth factor receptor alpha [EC:2.7.10.1 ]
K04364 GRB2; growth factor receptor-bound protein 2
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1 ]
K04377 MYC; Myc proto-oncogene protein
K04503 CCND1; G1/S-specific cyclin-D1
K04570 BCL2L1, bcl-xL; Bcl-2-like 1 (apoptosis regulator Bcl-X)
K04692 STAT3; signal transducer and activator of transcription 3
K04693 IRF9, ISGF3G, P48; interferon regulatory factor 9
K04694 SOCS1, JAB; suppressor of cytokine signaling 1
K04695 SOCS2, CIS2; suppressor of cytokine signaling 2
K04696 SOCS3, CIS3; suppressor of cytokine signaling 3
K04697 SOCS4; suppressor of cytokine signaling 4
K04698 SOCS5; suppressor of cytokine signaling 5
K04699 SOCS6_7; suppressor of cytokine signaling 6/7
K04701 CISH; cytokine inducible SH2-containing protein
K04702 PIM1; proto-oncogene serine/threonine-protein kinase Pim-1 [EC:2.7.11.1 ]
K04705 STAM; signal transducing adaptor molecule
K04706 PIAS1; E3 SUMO-protein ligase PIAS1 [EC:2.3.2.-]
K04737 IL3RA, CD123; interleukin 3 receptor alpha
K04738 CSF2RB, IL3RB, CD131; cytokine receptor common subunit beta
K05055 IL6R, CD126; interleukin 6 receptor
K05056 IL11RA; interleukin 11 receptor alpha
K05057 OSMR; oncostatin M receptor
K05058 LIFR, CD118; leukemia inhibitory factor receptor
K05059 CNTFR; ciliary neurotrophic factor receptor
K05060 IL6ST, GP130, CD130; interleukin 6 signal transducer
K05061 CSF3R, CD114; granulocyte colony-stimulating factor receptor
K05062 LEPR, CD295; leptin receptor
K05063 IL12RB1, CD212; interleukin 12 receptor beta-1
K05064 IL12RB2; interleukin 12 receptor beta-2
K05065 IL23R; interleukin 23 receptor
K05066 CSF2RA, GMCSFR, CD116; granulocyte-macrophage colony-stimulating factor receptor alpha
K05067 IL5RA, CD125; interleukin 5 receptor alpha
K05068 IL2RA, CD25; interleukin 2 receptor alpha
K05069 IL2RB, CD122; interleukin 2 receptor beta
K05070 IL2RG, CD132; interleukin 2 receptor gamma
K05071 IL4R, CD124; interleukin 4 receptor
K05072 IL7R, CD127; interleukin 7 receptor
K05073 IL9R, CD129; interleukin 9 receptor
K05074 IL15RA, CD215; interleukin 15 receptor alpha
K05075 IL21R, CD360; interleukin 21 receptor
K05076 IL13RA1, CD213A1; interleukin 13 receptor alpha-1
K05077 IL13RA2, CD213A2; interleukin 13 receptor alpha-2
K05078 TSLPR; thymic stromal-derived lymphopoietin receptor
K05079 EPOR; erythropoietin receptor
K05080 GHR; growth hormone receptor
K05081 PRLR; prolactin receptor
K05082 TPOR, MPL, CD110; thrombopoietin receptor
K05089 PDGFRB, CD140B; platelet-derived growth factor receptor beta [EC:2.7.10.1 ]
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K05132 IFNGR1, CD119; interferon gamma receptor 1
K05133 IFNGR2; interferon gamma receptor 2
K05134 IL10RA, CD210A; interleukin 10 receptor alpha
K05135 IL10RB, CD210B; interleukin 10 receptor beta
K05136 IL20RA; interleukin 20 receptor alpha
K05137 IL20RB; interleukin 20 receptor beta
K05138 IL22RA1; interleukin 22 receptor alpha 1
K05139 IL22RA2; interleukin 22 receptor alpha 2
K05140 IFNLR1, IL28RA; interferon lambda receptor 1
K05419 LIF; leukemia inhibitory factor
K05420 CNTF; ciliary neurotrophic factor
K05421 CLCF1, BSF3, CLC; cardiotrophin-like cytokine factor 1
K05422 CTF1, CT1; cardiotrophin 1
K05423 CSF3, GCSF; granulocyte colony-stimulating factor
K05426 IL23A; interleukin 23 subunit alpha
K05427 CSF2, GMCSF; granulocyte-macrophage colony-stimulating factor
K05436 TSLP; thymic stromal lymphopoietin
K05442 IFNE; interferon epsilon
K05443 IL10, CSIF; interleukin 10
K05445 IL22, IL-TIF; interleukin 22
K05447 IFNL1, IL29; interferon lambda 1
K05640 GFAP; glial fibrillary acidic protein
K05697 PTPN6, SHP1; tyrosine-protein phosphatase non-receptor type 6 [EC:3.1.3.48 ]
K06625 CDKN1A, P21, CIP1; cyclin-dependent kinase inhibitor 1A
K07203 MTOR, FRAP, TOR; serine/threonine-protein kinase mTOR [EC:2.7.11.1 ]
K07293 PTPN11, SHP2; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48 ]
K10151 CCND2; G1/S-specific cyclin-D2
K10152 CCND3; G1/S-specific cyclin-D3
K11220 STAT1; signal transducer and activator of transcription 1
K11221 STAT2; signal transducer and activator of transcription 2
K11222 STAT4; signal transducer and activator of transcription 4
K11223 STAT5A; signal transducer and activator of transcription 5A
K11224 STAT5B; signal transducer and activator of transcription 5B
K11225 STAT6; signal transducer and activator of transcription 6
K14365 FHL1, SLIM1; four and a half LIM domains protein 1
K16063 PIAS2; E3 SUMO-protein ligase PIAS2 [EC:2.3.2.-]
K16064 PIAS3; E3 SUMO-protein ligase PIAS3 [EC:2.3.2.-]
K17386 PDGFB; platelet-derived growth factor subunit B
K18026 PTPN2, PTPT; tyrosine-protein phosphatase non-receptor type 2 [EC:3.1.3.48 ]
K19598 IL27RA; interleukin 27 receptor alpha
K19599 DOME; cytokine receptor domeless
K22629 IL27, IL27A; interleukin 27 subunit alpha
K22630 IL31RA; interleukin 31 receptor subunit alpha
K22669 IFNL2_3, IL28; interferon lambda 2/3
Reference
Authors
Harrison DA
Title
The Jak/STAT pathway.
Journal
Reference
Authors
Kiu H, Nicholson SE
Title
Biology and significance of the JAK/STAT signalling pathways.
Journal
Reference
Authors
Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I
Title
Direct effects of type I interferons on cells of the immune system.
Journal
Reference
Authors
Fish EN, Platanias LC
Title
Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.
Journal
Reference
Authors
Ivanenkov YA, Balakin KV, Lavrovsky Y
Title
Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics.
Journal
Reference
Authors
O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A
Title
The JAK-STAT pathway: impact on human disease and therapeutic intervention.
Journal
Reference
Authors
Zoranovic T, Grmai L, Bach EA
Title
Regulation of proliferation, cell competition, and cellular growth by the Drosophila JAK-STAT pathway.
Journal
Reference
Authors
Ungureanu D, Silvennoinen O
Title
SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.
Journal
Reference
Authors
Richard AJ, Stephens JM
Title
The role of JAK-STAT signaling in adipose tissue function.
Journal
Reference
Authors
Sun Y, Lehmbecker A, Kalkuhl A, Deschl U, Sun W, Rohn K, Tzvetanova ID, Nave KA, Baumgartner W, Ulrich R
Title
STAT3 represents a molecular switch possibly inducing astroglial instead of oligodendroglial differentiation of oligodendroglial progenitor cells in Theiler's murine encephalomyelitis.
Journal
Reference
Authors
Hirano T, Ishihara K, Hibi M
Title
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
Journal
Reference
Authors
Rane SG, Reddy EP
Title
Janus kinases: components of multiple signaling pathways.
Journal
Reference
Authors
Heim MH
Title
The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus.
Journal
Reference
Authors
Morris R, Kershaw NJ, Babon JJ
Title
The molecular details of cytokine signaling via the JAK/STAT pathway.
Journal
Reference
Authors
Tzeng HT, Chyuan IT, Lai JH
Title
Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Journal
Reference
Authors
Salas A, Hernandez-Rocha C, Duijvestein M, Faubion W, McGovern D, Vermeire S, Vetrano S, Vande Casteele N
Title
JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.
Journal
Related pathway
ko04060 Cytokine-cytokine receptor interaction
ko04120 Ubiquitin mediated proteolysis